Pirow Bekker

机构：ChemoCentryx (United States) · ORCID：0000-0003-0219-7188

发表论文 118 篇 · 总被引 8323 次 · h-index 30

代表论文

• The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time (2022 · Seminars in Arthritis and Rheumatism · 被引 99)
• Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan (2023 · Kidney International Reports · 被引 90)
• C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study (2021 · Clinical Kidney Journal · 被引 88)
• The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial (2023 · The Lancet Rheumatology · 被引 31)
• POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY (2022 · Kidney International Reports · 被引 23)
• Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial (2023 · The Lancet Rheumatology · 被引 20)